tiprankstipranks
Trending News
More News >
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market

Black Diamond Therapeutics (BDTX) Income Statement

Compare
1,580 Followers

Black Diamond Therapeutics Income Statement

Last quarter (Q3 2025), Black Diamond Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Black Diamond Therapeutics's net income was $-8.50M. See Black Diamond Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -437.00K$ 0.00$ 0.00$ -600.00K
Operating Expenses
$ 78.78M$ 86.02M$ 92.83M$ 126.87M$ 69.57M
Depreciation and Amortization
$ 343.00K$ 437.00K$ 508.00K$ 205.00K$ 600.00K
EBITDA
$ -78.44M$ -86.02M$ -92.32M$ -126.67M$ -66.65M
Operating Income
$ -78.78M$ -86.46M$ -92.83M$ -126.87M$ -69.57M
Other Income/Expenses
$ 9.11M$ 4.02M$ 1.66M$ 1.28M$ 2.32M
Pretax Income
$ -69.68M$ -82.44M$ -91.17M$ -125.60M$ -67.25M
Net Income
$ -69.68M$ -82.44M$ -91.17M$ -125.60M$ -67.25M
Per Share Metrics
Basic EPS
$ -1.27$ -1.88$ -2.52$ -3.47$ -2.04
Diluted EPS
$ -1.27$ -1.88$ -2.52$ -3.47$ -2.04
Weighted Average Shares Outstanding
55.03M 43.95M 36.23M 36.19M 32.91M
Weighted Average Shares Outstanding (Diluted)
55.03M 43.95M 36.23M 36.19M 32.91M
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History